Experts urge renewed push on US-Thai HIV vaccine

Health experts today called for trials of an HIV vaccine under development in Thailand to be speeded up following recent setbacks in other efforts to end the AIDS epidemic.

Initial test results of the RV144 vaccine — jointly developed by US military researchers and the Thai health ministry — in 2009 found a 31 per cent protection rate among 16,000 Thai volunteers.

Phase IIb trials could start next year in the kingdom, a major forum in Bangkok heard.

Experts are optimistic a modified version of the vaccine will raise the protection rate to around 50 per cent — the figure needed to obtain regulatory approval for public release.

Business Standard
Read More

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below